Skip to main content Skip to main menu
UF Health University of Florida
Department of Pharmaceutical Outcomes & Policy College of Pharmacy
Shailina A Keshwani

Shailina A Keshwani, Ph.D., M.S.

Research Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6268
Business Email: skeshwani@ufl.edu
CV: View Curriculum Vitae

About Shailina A Keshwani

Shailina Keshwani, Ph.D., M.S., is a Research Assistant Professor in the Department of Pharmaceutical Outcomes and Policy at the University of Florida, working under the supervision of Dr. Steven Smith. She earned her Bachelor of Science in Pharmacy from Mumbai University in 2012. She completed a Master of Science in Pharmaceutical Sciences at the University of Florida in 2021, followed by a PhD in Pharmaceutical Sciences from the same department in Spring 2025. Dr. Keshwani’s research focuses on the intersection of pain management and cardiovascular diseases, with particular emphasis on the use of analgesics in patients with cardiovascular comorbidities that may contraindicate such treatments. Her work aims to enhance the understanding of analgesic safety and effectiveness in geriatric patients, ultimately contributing to safer, evidence-based approaches to pain management.

Research Profile

Areas of Interest
  • Chronic Pain
  • Hypertension
  • Impact of health policy related to prescribing practices
  • Pharmacoepidemiology

Publications

Academic Articles
2025
Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly-Treated Patients with Hypertension.
American journal of hypertension. [DOI] 10.1093/ajh/hpaf060. [PMID] 40259567.
PubMed · Publisher’s Site
2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-Converting Enzyme Inhibitor Initiators.
Pharmacoepidemiology and drug safety. 34(3) [DOI] 10.1002/pds.70132. [PMID] 40098294.
1 citation · PubMed · Publisher’s Site
2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) Initiators.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2025.03.10.25323711. [PMID] 40162241.
1 citation · PubMed · Publisher’s Site
2024
Initial Antihypertensive Prescribing in Relation to Blood Pressure Among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
Hypertension. 81(2):e7-e9 [DOI] 10.1161/hypertensionaha.123.21901. [PMID] 38232142.
PubMed · Publisher’s Site
2023
Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Journal of the American Heart Association. 12(1) [DOI] 10.1161/JAHA.122.026652. [PMID] 36565195.
7 citations · PubMed · Publisher’s Site
2023
Modifiable statin characteristics associated with potential statin-related prescribing cascades.
Pharmacotherapy. 43(12):1307-1316 [DOI] 10.1002/phar.2883. [PMID] 37771303.
1 citation · PubMed · Publisher’s Site
2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016.
The journal of pain. 24(11):1994-2002 [DOI] 10.1016/j.jpain.2023.06.008. [PMID] 37330160.
4 citations · PubMed · Publisher’s Site
2022
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
JAMA health forum. 3(6) [DOI] 10.1001/jamahealthforum.2022.1757. [PMID] 35977240.
25 citations · PubMed · Publisher’s Site
2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.
Medical cannabis and cannabinoids. 4(1):21-42 [DOI] 10.1159/000515069. [PMID] 34676348.
22 citations · PubMed · Publisher’s Site
2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
JAMA network open. 4(6) [DOI] 10.1001/jamanetworkopen.2021.13383. [PMID] 34115125.
9 citations · PubMed · Publisher’s Site

Education

PhD
2025 · University of Florida
MS
2021 · University of Florida
BAS
2017 · College of Central Florida
BS
2012 · Mumbai University

Contact Details

Phones:
Business:
(352) 273-6268
Emails:
Business:
skeshwani@ufl.edu
Addresses:
Business Mailing:
PO Box 100496
 GAINESVILLE FL 32610
Business Street:
1889 MUSEUM RD STE 6300
MALACHOWSKY HALL
 GAINESVILLE FL 32611